CD40 induces antigen transporter and immunoproteasome gene expression in carcinomas via the coordinated action of NF-kappaB and of NF-kappaB-mediated de novo synthesis of IRF-1.
about
Identification of E2F1 as an important transcription factor for the regulation of tapasin expression.IRF1 and NF-kB restore MHC class I-restricted tumor antigen processing and presentation to cytotoxic T cells in aggressive neuroblastomaPotential role of LMP2 as tumor-suppressor defines new targets for uterine leiomyosarcoma therapy.The hydroxyflavone, fisetin, suppresses mast cell activation induced by interaction with activated T cell membranes.Connecting myelin-related and synaptic dysfunction in schizophrenia with SNP-rich gene expression hubs.Identification of IRF1 as critical dual regulator of Smac mimetic-induced apoptosis and inflammatory cytokine response.Enhanced therapeutic anti-tumor immunity induced by co-administration of 5-fluorouracil and adenovirus expressing CD40 ligand.Removal of damaged proteins during ES cell fate specification requires the proteasome activator PA28The death domain kinase RIP1 links the immunoregulatory CD40 receptor to apoptotic signaling in carcinomas.Viral IL-10 down-regulates the "MHC-I antigen processing operon" through the NF-κB signaling pathway in nasopharyngeal carcinoma cells.HMME-based PDT restores expression and function of transporter associated with antigen processing 1 (TAP1) and surface presentation of MHC class I antigen in human glioma.Proteasome dysregulation in human cancer: implications for clinical therapies.Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer.
P2860
Q30318613-EBD24184-20E9-41F9-BEF9-E6BBDD04BD82Q34447613-BB737103-CBAF-4C1E-BF02-80C3262D70ACQ35619604-479D8F11-D1F8-454C-AC94-8AAE14CE8451Q37395933-1A8E047B-CF77-480A-B8A9-B1B69553E51AQ38850829-0EEA21D9-C30D-4F65-9831-872F59B1FBB5Q38929174-F4040960-B22D-4348-90B5-11C90E8FE4CFQ39041608-88B43D88-F2DE-454F-A810-CD29B5FB3C96Q39185542-EE29EAA5-6129-4AEC-8F62-6D598A442DCDQ39599925-18AC38A3-2F42-49BF-A1DA-26BC5EA58B18Q40572956-3F32AABB-FEF7-4F96-BBA2-C1D1EC788380Q46831195-42858AD9-16B2-4BE9-A48F-8EF8BC09A256Q50077966-843705E3-F62F-4F43-92C6-1E0F6DC1C05EQ51679220-9871F409-C729-46B5-97F5-EF74028DE075
P2860
CD40 induces antigen transporter and immunoproteasome gene expression in carcinomas via the coordinated action of NF-kappaB and of NF-kappaB-mediated de novo synthesis of IRF-1.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
CD40 induces antigen transport ...... ed de novo synthesis of IRF-1.
@en
CD40 induces antigen transport ...... ed de novo synthesis of IRF-1.
@nl
type
label
CD40 induces antigen transport ...... ed de novo synthesis of IRF-1.
@en
CD40 induces antigen transport ...... ed de novo synthesis of IRF-1.
@nl
prefLabel
CD40 induces antigen transport ...... ed de novo synthesis of IRF-1.
@en
CD40 induces antigen transport ...... ed de novo synthesis of IRF-1.
@nl
P2093
P2860
P356
P1476
CD40 induces antigen transport ...... ted de novo synthesis of IRF-1
@en
P2093
Aristides Moschonas
Dimitris Kardassis
Efstathia Thymiakou
Maria Kouraki
Pauline G Knox
P2860
P304
P356
10.1128/MCB.00611-08
P407
P577
2008-08-11T00:00:00Z